TreatGut Pharmaceutical Group, founded in 2016, is a national high-tech enterprise that provides overall solutions for Precision Microbiota Transplantation. The company integrates R&D, intelligent manufacturing, sales and service, focusing on human microecological transplantation. Its business fields span microecological health, microecological diagnosis, microecological treatment, microecological drugs, and microecological medical big data mining. It is a national high-tech enterprise. After several years of development, the company has become a leader in the industry. The group is headquartered in Shanghai and has four business divisions: TreatGut Biology Division, TreatGut Health Division, TreatGut Medical Division, and TreatGut Intelligent Pharmaceuticals Division. In 2022, the company began to implement group management, with R&D bases in Shanghai, Xiamen, and Singapore, and subsidiaries in Beijing, Guangzhou, Shenzhen, Hefei, Qingdao, Xiamen, Yichun, Suzhou, Shijiazhuang, Ningde, Shenyang, Qingdao, and Hefei.

TreatGut Pharmaceutical Group is the only company in the field of microbiota transplantation in China that has obtained the human genetic resources registration license from the Ministry of Science and Technology. It is also the only company approved by "CNAS" and has six complete certificates. It has built six world-leading core technology platforms: Precision Microbiota Transplantation treatment platform, gut microbiota industrial extraction platform, microbial preparation medical device technology platform, clinical microbial detection technology platform, microecological medical big data cloud platform, and microbial drug screening and development platform. Based on the core technology of "Precision Microbiota Transplantation", it provides five major solutions and builds a business system with bacterial libraries as the core; it has vigorously deployed in five major areas of the microecological industry: including TreatGut Biology technology, TreatGut Health, TreatGut Medical Testing, TreatGut Intelligent Pharmaceuticals, and Micro-ecological Future Hospital, create a complete closed-loop micro-ecological medical system and build an intensive solution-oriented enterprise for the entire micro-ecological industry chain. Currently, it has provided professional services to more than 300+ medical institutions, with more than 300,000 microbiota transplantation and gut microbiota testing performed.